VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11 | -100.0% | 107,494 | -87.4% | 0.00% | – |
Q3 2022 | $130,000 | -83.1% | 854,611 | -2.1% | 0.00% | – |
Q2 2022 | $768,000 | -50.1% | 872,959 | -29.6% | 0.00% | -100.0% |
Q1 2022 | $1,538,000 | +7223.8% | 1,240,285 | +11622.9% | 0.00% | – |
Q4 2021 | $21,000 | -98.3% | 10,580 | -97.6% | 0.00% | -100.0% |
Q3 2021 | $1,220,000 | +119.0% | 445,338 | +152.0% | 0.00% | – |
Q2 2021 | $557,000 | -81.3% | 176,707 | -87.3% | 0.00% | -100.0% |
Q1 2021 | $2,974,000 | +96.2% | 1,396,389 | +78.6% | 0.00% | +100.0% |
Q4 2020 | $1,516,000 | +5314.3% | 781,685 | +4097.4% | 0.00% | – |
Q4 2018 | $28,000 | – | 18,623 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |